In the News
Do you really need that MRI?
Dr. Arthur Hong’s study explores why physicians often order unnecessary radiographic imaging for common headaches and back ailments.
Dr. Hammers co-led team on immunotherapy treatment
A combination immunotherapy treatment showed better overall survival in patients with previously untreated advanced or metastatic renal cell carcinoma than current therapy, according to results from a phase 3 clinical trial presented at the Presidential Symposium of the European Society for Medical Oncology 2017 Annual Meeting in Spain.
Dr. Joshi uses family history in South Asians as diagnostic indicator
New research by UT Southwestern cardiologists shows that people of South Asian descent with a family history of coronary heart disease are significantly more likely to have high levels of calcium buildup in their arteries – an indicator of higher risk for heart attacks.
Dr. Scherer to receive international award for diabetes research
Dr. Philipp Scherer, Director of the Touchstone Center for Diabetes Research at UT Southwestern, will receive the 2017 EASD-Novo Nordisk Foundation Diabetes Prize for Excellence in recognition of his research that explains the relationship between body fat and type 2 diabetes.
Drs. Singal and Halm publish finding on colon cancer screening
Sending a letter and, in some cases, a simple mail-in kit tripled colon cancer screening completion among low-income adults, say Dr. Amit Singal and Dr. Ethan Halm.
Dr. Gerber reviews obstacles to clinical trial eligibility
Despite a decade-long call for simplification of clinical trials, the number of criteria excluding patients from participating in clinical trials for lung cancer research continues to rise.
Dr. Brugarolas helps to unlock mystery of aggressive kidney cancer
A long-standing question across oncology is why the same cancer may be very aggressive in some patients but not in others. Researchers with the Kidney Cancer Program of UT Southwestern Medical Center’s Harold C. Simmons Comprehensive Cancer Center have uncovered how kidney cancer aggressiveness is determined.